TSRL

Tsrl

Pharmaceuticals, 540 Avis Dr, Ann Arbor, Michigan, 48108, United States, 11-50 Employees

tsrlinc.com

  • twitter
  • LinkedIn

phone no Phone Number: 73********

Who is TSRL

Therapeutic Systems Research Laboratories (TSRL), Inc. is a privately women-owned, pre-clinical accelerator based in Ann Arbor, Michigan focused on building companies that develop infecti...

Read More

map
  • 540 Avis Dr, Ann Arbor, Michigan, 48108, United States Headquarters: 540 Avis Dr, Ann Arbor, Michigan, 48108, United States
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $25 Million to $50 Million

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 5052 | NAICS Code: 423610 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from TSRL

TSRL Org Chart and Mapping

Employees

Paul Kijek

Manager of Analytical Services

Megan Devries

Administrative Assistant

Emily Oliver

Assistant Research Scientist

Dawn Kuszynski

Research/Project Scientist

Penny Weller

Office/Facilities Manager at Therapeutic Systems Research Laboratory (Tsrl)

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding TSRL

Answer: TSRL's headquarters are located at 540 Avis Dr, Ann Arbor, Michigan, 48108, United States

Answer: TSRL's phone number is 73********

Answer: TSRL's official website is https://tsrlinc.com

Answer: TSRL's revenue is $25 Million to $50 Million

Answer: TSRL's SIC: 5052

Answer: TSRL's NAICS: 423610

Answer: TSRL has 11-50 employees

Answer: TSRL is in Pharmaceuticals

Answer: TSRL contact info: Phone number: 73******** Website: https://tsrlinc.com

Answer: Therapeutic Systems Research Laboratories (TSRL), Inc. is a privately women-owned, pre-clinical accelerator based in Ann Arbor, Michigan focused on building companies that develop infectious disease therapeutics. A key aspect of our strategy is our Technology Accelerator, an ongoing collaborative process that lends our expertise and capabilities to entrepreneurs seeking to obtain the data and non-dilutive funding necessary to develop and/or commercialize their inventions. One focus is improving existing drug products by applying our versatile prodrug platform technologies to optimize therapy regimen for treating infectious diseases. Potential target indications include: influenza, HSV, VZV, CMV, EBV, poxvirus, HPV, Adenovirus, and RNA viruses. We currently employ ten full-time employees and a number of drug development consultants and generate annual revenues of approximately $2M from royalties and grants. Our team has broad experience in chemistry, molecular biology, biochemistry, analytical chemistry, in vivo animal model, PK/ADME, toxicology and formulation. Our research is conducted in a 7,200 sq. ft. facility of which 5,000 sq. ft. is wet lab space, with on-site analytical chemistry, formulation, cell culture equipment and in vivo testing capabilities.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access